midazolam has been researched along with Delirium in 89 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
Delirium: A disorder characterized by CONFUSION; inattentiveness; disorientation; ILLUSIONS; HALLUCINATIONS; agitation; and in some instances autonomic nervous system overactivity. It may result from toxic/metabolic conditions or structural brain lesions. (From Adams et al., Principles of Neurology, 6th ed, pp411-2)
Excerpt | Relevance | Reference |
---|---|---|
"To investigate the influence of the midazolam sedation based on remifentanil analgesia on the occurrence of delirium in critically ill patients in intensive care unit (ICU)." | 9.20 | [The influence of the sedation based on remifentanil analgesia on the occurrence of delirium in critically ill patients]. ( An, Y; Feng, Y; Liu, D; Lyu, J, 2015) |
"To determine whether dexmedetomidine sedation in the postanesthesia care unit (PACU) could decrease agitation and delirium after free flap surgery." | 9.20 | Effect of dexmedetomidine on preventing agitation and delirium after microvascular free flap surgery: a randomized, double-blind, control study. ( Gao, C; Li, Z; Liu, R; Yang, X, 2015) |
"Dexmedetomidine was associated with the decreased postoperative fentanyl consumption, NVAS scores, and a decreased incidence of delirium." | 9.17 | Pain, fentanyl consumption, and delirium in adolescents after scoliosis surgery: dexmedetomidine vs midazolam. ( Aydogan, MS; Colak, C; Durmus, M; Erdogan, MA; Karaman, A; Korkmaz, MF; Ozgül, U; Togal, T; Yucel, A, 2013) |
" This, however, does not result in a reduced incidence of emergence delirium after sevoflurane anesthesia." | 9.12 | Midazolam does not reduce emergence delirium after sevoflurane anesthesia in children. ( Breschan, C; Jost, R; Likar, R; Platzer, M; Stettner, H, 2007) |
"5 micrograms/kg dexmedetomidine is effective in attenuating the cardiostimulatory and postanesthetic delirium effects of ketamine." | 9.08 | Dexmedetomidine premedication attenuates ketamine-induced cardiostimulatory effects and postanesthetic delirium. ( Levänen, J; Mäkelä, ML; Scheinin, H, 1995) |
"A comprehensive literature search was conducted to identify clinical trials that observed the effect of midazolam and clonidine on preventing EA in children after their emergence from sevoflurane anesthesia." | 8.89 | Prophylactic midazolam and clonidine for emergence from agitation in children after emergence from sevoflurane anesthesia: a meta-analysis. ( Li, J; Wang, Y; Zhang, C; Zhao, D, 2013) |
"To observe the association between exposure to midazolam within 24 hours prior to delirium assessment and the risk of delirium." | 8.12 | Effect of midazolam on delirium in critically ill patients: a propensity score analysis. ( Chen, JH; Hu, AM; Shi, HJ; Yuan, RX; Zhang, JZ, 2022) |
"This was a prospective observational cohort pilot study identifying the prevalence of delirium pre-procedure and incidence of delirium post-procedure in elderly endoscopy patients receiving midazolam." | 8.02 | A prospective observational cohort pilot study of the association between midazolam use and delirium in elderly endoscopy patients. ( Chapman, G; Fernando, J; Hayman, M; Lee, D; Petersen, F; Tomkins, K; Wu, M, 2021) |
"Premedication using midazolam was not associated with higher incidence of delirium on the first postoperative day in older patients undergoing major noncardiac surgery." | 8.02 | Midazolam Premedication Immediately Before Surgery Is Not Associated With Early Postoperative Delirium. ( Leung, JM; Min, J; Sands, LP; Wang, ML, 2021) |
" Dexmedetomidine significantly decreased the ICU LOS and ICU LOS after the occurrence of delirium compared to haloperidol (13." | 7.83 | Use of Dexmedetomidine in Liver Transplant Recipients With Postoperative Agitated Delirium. ( Choi, JY; Gwak, MS; Joh, JW; Kim, GS; Kim, JM; Kim, SJ; Ko, JS; Kwon, CH; Lee, S; Lee, SK; Park, JB, 2016) |
" We present the case of a healthy 12-year-old girl who received preoperative midazolam with the desired anxiolytic effect, underwent a brief general anesthetic, and then exhibited postoperative delirium, consisting of a transient associative agnosia and expressive aphasia." | 7.81 | Emergence delirium with transient associative agnosia and expressive aphasia reversed by flumazenil in a pediatric patient. ( Cook-Sather, SD; DiPuppo, PM; Drobish, JK; Kelz, MB, 2015) |
"Time to first coma was associated with fentanyl and midazolam doses (p=0." | 7.79 | Factors predisposing to coma and delirium: fentanyl and midazolam exposure; CYP3A5, ABCB1, and ABCG2 genetic polymorphisms; and inflammatory factors. ( Cossette, M; Leger, C; Michaud, V; Skrobik, Y; Turgeon, J, 2013) |
"This study examined the relationship between nurses' pro re nata administration of midazolam hydrochloride to cardiac surgery patients and the development of post-operative delirium." | 7.78 | The association between nurse-administered midazolam following cardiac surgery and incident delirium: an observational study. ( Fernandes, C; Galdas, PM; Gallaher, J; Jillings, C; Manning, D; Ratner, PA; Taipale, PG, 2012) |
"Dexmedetomidine may help to eliminate the emergence of agitation and can be a good treatment choice for the delirium state after cardiac surgery." | 7.77 | Dexmedetomidine in cardiac surgery patients who fail extubation and present with a delirium state. ( Aykac, Z; Can, Y; Coruh, T; Kehlibar, T; Ozler, A; Tarhan, A; Yapici, F; Yapici, N, 2011) |
" Although delirium caused by midazolam or propofol in different patients has been reported, the present case represents a delirium that developed from both drugs in the same patient, possibly because of the patient's smaller tolerance to midazolam and propofol." | 7.73 | Delirium during intravenous sedation with midazolam alone and with propofol in dental treatment. ( Inada, H; Jinno, S; Kohase, H; Mohri-Ikuzawa, Y; Takahashi, N; Umino, M, 2006) |
"We report a case of emergence delirium in a 26-month-old girl after she received oral midazolam to achieve conscious sedation." | 7.69 | Emergence delirium in a child given oral midazolam for conscious sedation. ( Doyle, WL; Perrin, L, 1994) |
"The symptoms of disorientation, restlessness, inconsolable crying and thrashing resemble an acute psychosis similar to an agitated central anticholinergic syndrome." | 6.73 | Physostigmine and anaesthesia emergence delirium in preschool children: a randomized blinded trial. ( Funk, W; Geroldinger, J; Hollnberger, H, 2008) |
"When midazolam was administered for the treatment of severe agitation it reduced the severity but did not abolish agitation." | 6.70 | [Prevention of "post-sevoflurane delirium" with midazolam]. ( Bressem, M; Kulka, PJ; Tryba, M; Wiebalck, A, 2001) |
"Midazolam is a widely used short-acting benzodiazepine." | 5.72 | Midazolam impacts acetyl-And butyrylcholinesterase genes: An epigenetic explanation for postoperative delirium? ( Adamzik, M; Bazzi, M; Bazzi, Z; Bergmann, L; Holtkamp, C; Koos, B; Nowak, H; Orlowski, J; Rahmel, T; Rump, K; Thon, P; Unterberg, M, 2022) |
"Combined with recent evidence, compared with midazolam, dexmedetomidine decreased the risk of delirium, mechanical ventilation, length of stay in the ICU, as well as reduced patient costs." | 5.41 | A comparation of dexmedetomidine and midazolam for sedation in patients with mechanical ventilation in ICU: A systematic review and meta-analysis. ( Ding, X; Jiang, W; Liu, C; Liu, X; Wei, X; Wen, J; Xu, Y, 2023) |
" Emergency surgery, more doses of midazolam, and fentanyl may be independent risk factors for SAD in mechanically ventilated patients with sepsis." | 5.34 | Incidence, risk factors, and outcomes for sepsis-associated delirium in patients with mechanical ventilation: A sub-analysis of a multicenter randomized controlled trial. ( Kawazoe, Y; Miyamoto, K; Mizobata, Y; Morimoto, T; Ohta, Y; Yamamoto, T; Yamamura, H, 2020) |
" Within the three study groups, no significant change was objectified in the anxiety level from baseline to separation from parents (mean change in mYPAS midazolam group: 2." | 5.24 | Childhood preoperative anxiolysis: Is sedation and distraction better than either alone? A prospective randomized study. ( Bringuier, S; Capdevila, X; Dadure, C; Lefauconnier, A; Raux, O; Sola, C, 2017) |
" Dexmedetomidine was associated with a significant increase in extubation quality compared with midazolam, reflected in the prevalence of delirium after extubation (20% (8/40) vs 45% (18/40)), respectively (p= 0." | 5.22 | Clinical study of midazolam sequential with dexmedetomidine for agitated patients undergoing weaning to implement light sedation in intensive care unit. ( Gao, XJ; Li, J; Li, T; Li, ZB; Lu, X; Xu, L; Zhang, J, 2016) |
"To determine whether dexmedetomidine sedation in the postanesthesia care unit (PACU) could decrease agitation and delirium after free flap surgery." | 5.20 | Effect of dexmedetomidine on preventing agitation and delirium after microvascular free flap surgery: a randomized, double-blind, control study. ( Gao, C; Li, Z; Liu, R; Yang, X, 2015) |
"The sedative effects of dexmedetomidine in the ICU patients treated with ventilator bundle treatment are satisfactory, and it can shorten the duration of mechanical ventilation, extubation time and length of ICU stay, reduce the incidence of delirium." | 5.20 | [A study of using dexmedetomidine in ventilator bundle treatment in an ICU]. ( Dong, C; Li, J; Song, R; Yang, J, 2015) |
"To investigate the influence of the midazolam sedation based on remifentanil analgesia on the occurrence of delirium in critically ill patients in intensive care unit (ICU)." | 5.20 | [The influence of the sedation based on remifentanil analgesia on the occurrence of delirium in critically ill patients]. ( An, Y; Feng, Y; Liu, D; Lyu, J, 2015) |
"Dexmedetomidine was associated with the decreased postoperative fentanyl consumption, NVAS scores, and a decreased incidence of delirium." | 5.17 | Pain, fentanyl consumption, and delirium in adolescents after scoliosis surgery: dexmedetomidine vs midazolam. ( Aydogan, MS; Colak, C; Durmus, M; Erdogan, MA; Karaman, A; Korkmaz, MF; Ozgül, U; Togal, T; Yucel, A, 2013) |
" Secondary end points included prevalence and duration of delirium, use of fentanyl and open-label midazolam, and nursing assessments." | 5.14 | Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. ( Bokesch, PM; Byrne, DW; Ceraso, D; Ely, EW; Koura, F; Margolis, BD; Riker, RR; Rocha, MG; Shehabi, Y; Whitten, P; Wisemandle, W, 2009) |
" This, however, does not result in a reduced incidence of emergence delirium after sevoflurane anesthesia." | 5.12 | Midazolam does not reduce emergence delirium after sevoflurane anesthesia in children. ( Breschan, C; Jost, R; Likar, R; Platzer, M; Stettner, H, 2007) |
"5 micrograms/kg dexmedetomidine is effective in attenuating the cardiostimulatory and postanesthetic delirium effects of ketamine." | 5.08 | Dexmedetomidine premedication attenuates ketamine-induced cardiostimulatory effects and postanesthetic delirium. ( Levänen, J; Mäkelä, ML; Scheinin, H, 1995) |
"A comprehensive literature search was conducted to identify clinical trials that observed the effect of midazolam and clonidine on preventing EA in children after their emergence from sevoflurane anesthesia." | 4.89 | Prophylactic midazolam and clonidine for emergence from agitation in children after emergence from sevoflurane anesthesia: a meta-analysis. ( Li, J; Wang, Y; Zhang, C; Zhao, D, 2013) |
"To observe the association between exposure to midazolam within 24 hours prior to delirium assessment and the risk of delirium." | 4.12 | Effect of midazolam on delirium in critically ill patients: a propensity score analysis. ( Chen, JH; Hu, AM; Shi, HJ; Yuan, RX; Zhang, JZ, 2022) |
"This was a prospective observational cohort pilot study identifying the prevalence of delirium pre-procedure and incidence of delirium post-procedure in elderly endoscopy patients receiving midazolam." | 4.02 | A prospective observational cohort pilot study of the association between midazolam use and delirium in elderly endoscopy patients. ( Chapman, G; Fernando, J; Hayman, M; Lee, D; Petersen, F; Tomkins, K; Wu, M, 2021) |
"Premedication using midazolam was not associated with higher incidence of delirium on the first postoperative day in older patients undergoing major noncardiac surgery." | 4.02 | Midazolam Premedication Immediately Before Surgery Is Not Associated With Early Postoperative Delirium. ( Leung, JM; Min, J; Sands, LP; Wang, ML, 2021) |
" Late awakening was more frequent with midazolam (58% vs 45%) and was associated with higher rates of delirium (62% vs 39%) and unfavorable 3-months outcome (27% vs 12%; all p = 0." | 3.91 | Late Awakening in Survivors of Postanoxic Coma: Early Neurophysiologic Predictors and Association With ICU and Long-Term Neurologic Recovery. ( Eckert, P; Miroz, JP; Oddo, M; Rey, A; Rossetti, AO, 2019) |
"These experiments identify a novel role for PER2 during a midazolam- or constant light-induced delirium-like state, highlight the importance of hippocampal PER2 expression for cognitive function, and suggest the PER2 enhancer nobiletin as potential therapy in delirium-like conditions associated with circadian disruption." | 3.88 | The Period 2 Enhancer Nobiletin as Novel Therapy in Murine Models of Circadian Disruption Resembling Delirium. ( Eckle, T; Gile, J; Scott, B, 2018) |
" Fentanyl, midazolam, and dexmedetomidine were the first choices of agents for analgesic, sedation, and delirium treatment." | 3.85 | A National Multicenter Survey on Management of Pain, Agitation, and Delirium in Intensive Care Units in China. ( Hu, B; Li, JG; Peng, ZY; Rao, X; Wang, J; Zhou, WH, 2017) |
"Older age, higher SOFA score, regular smoking, and higher maintenance dose of midazolam and fentanyl when patients met sequential criteria were independent risk factors of delirium in sequential sedation patients." | 3.85 | Risk Factors of Delirium in Sequential Sedation Patients in Intensive Care Units. ( Kang, Y; Lv, Y; Wang, P; Wang, Z; Xu, B; Yang, J; Zhou, Y, 2017) |
" Dexmedetomidine significantly decreased the ICU LOS and ICU LOS after the occurrence of delirium compared to haloperidol (13." | 3.83 | Use of Dexmedetomidine in Liver Transplant Recipients With Postoperative Agitated Delirium. ( Choi, JY; Gwak, MS; Joh, JW; Kim, GS; Kim, JM; Kim, SJ; Ko, JS; Kwon, CH; Lee, S; Lee, SK; Park, JB, 2016) |
"The World Health Organization recommends that anxiety, depression, agitation and delirium at end of life should be treated with drugs such as lorazepam, diazepam, midazolam and haloperidol." | 3.83 | Look again at psychedelic drugs. ( Cameron, R, 2016) |
" We present the case of a healthy 12-year-old girl who received preoperative midazolam with the desired anxiolytic effect, underwent a brief general anesthetic, and then exhibited postoperative delirium, consisting of a transient associative agnosia and expressive aphasia." | 3.81 | Emergence delirium with transient associative agnosia and expressive aphasia reversed by flumazenil in a pediatric patient. ( Cook-Sather, SD; DiPuppo, PM; Drobish, JK; Kelz, MB, 2015) |
" Midazolam, a benzodiazepine commonly administered to children for anxiolysis, may precipitate paradoxical agitation and delirium, a rare but alarming effect that warrants prompt identification and treatment." | 3.81 | Successful flumazenil reversal of paradoxical reaction to midazolam in a child. ( Beck, LA; Jackson, BF; Losek, JD, 2015) |
"Time to first coma was associated with fentanyl and midazolam doses (p=0." | 3.79 | Factors predisposing to coma and delirium: fentanyl and midazolam exposure; CYP3A5, ABCB1, and ABCG2 genetic polymorphisms; and inflammatory factors. ( Cossette, M; Leger, C; Michaud, V; Skrobik, Y; Turgeon, J, 2013) |
"This study examined the relationship between nurses' pro re nata administration of midazolam hydrochloride to cardiac surgery patients and the development of post-operative delirium." | 3.78 | The association between nurse-administered midazolam following cardiac surgery and incident delirium: an observational study. ( Fernandes, C; Galdas, PM; Gallaher, J; Jillings, C; Manning, D; Ratner, PA; Taipale, PG, 2012) |
"Dexmedetomidine may help to eliminate the emergence of agitation and can be a good treatment choice for the delirium state after cardiac surgery." | 3.77 | Dexmedetomidine in cardiac surgery patients who fail extubation and present with a delirium state. ( Aykac, Z; Can, Y; Coruh, T; Kehlibar, T; Ozler, A; Tarhan, A; Yapici, F; Yapici, N, 2011) |
"Three hundred fifty-four medical and surgical intensive care patients enrolled in the SEDCOM (Safety and Efficacy of Dexmedetomidine Compared with Midazolam) trial received a sedative study drug and completed at least one delirium assessment." | 3.76 | Delirium duration and mortality in lightly sedated, mechanically ventilated intensive care patients. ( Bokesch, PM; Ely, EW; Riker, RR; Shehabi, Y; Shintani, A; Wisemandle, W, 2010) |
" Although delirium caused by midazolam or propofol in different patients has been reported, the present case represents a delirium that developed from both drugs in the same patient, possibly because of the patient's smaller tolerance to midazolam and propofol." | 3.73 | Delirium during intravenous sedation with midazolam alone and with propofol in dental treatment. ( Inada, H; Jinno, S; Kohase, H; Mohri-Ikuzawa, Y; Takahashi, N; Umino, M, 2006) |
"We report a case of emergence delirium in a 26-month-old girl after she received oral midazolam to achieve conscious sedation." | 3.69 | Emergence delirium in a child given oral midazolam for conscious sedation. ( Doyle, WL; Perrin, L, 1994) |
"Five cases of post narcotic delirium, somnolence or coma are interpreted as central anticholinergic syndromes as they were reversed by physostigmine." | 3.66 | [Physostigmine reversal of central anticholinergic syndrome induced by midazolam/fentanyl, benzoctamine/buprenorphine and etomidate/carticaine or by atropine/promethazine/pethidine for premedication? (author's transl)]. ( Jost, U; Ruppert, M; Schmid, A, 1982) |
"Delirium is common during critical illness and associated with adverse outcomes." | 2.80 | Prevalence, risk factors, and outcomes of delirium in mechanically ventilated adults. ( Burns, K; Burry, L; Cook, D; Devlin, JW; Dodek, P; Ferguson, N; Fergusson, D; Fowler, R; Granton, J; Herridge, M; Jacka, M; Keenan, S; Mallick, R; Meade, M; Mehta, S; Olafson, K; Reynolds, S; Skrobik, Y; Steinberg, M; Tanios, M, 2015) |
"Propofol was given to 16 of 21 (76%) of early goal-directed sedation versus 16 of 16 (100%) of standard sedation patients (p = 0." | 2.78 | Early goal-directed sedation versus standard sedation in mechanically ventilated critically ill patients: a pilot study*. ( Bailey, M; Bass, F; Bellomo, R; Howe, B; McArthur, C; Murray, L; Reade, MC; Seppelt, IM; Shehabi, Y; Webb, S; Weisbrodt, L, 2013) |
"The symptoms of disorientation, restlessness, inconsolable crying and thrashing resemble an acute psychosis similar to an agitated central anticholinergic syndrome." | 2.73 | Physostigmine and anaesthesia emergence delirium in preschool children: a randomized blinded trial. ( Funk, W; Geroldinger, J; Hollnberger, H, 2008) |
"Patients in the ICU after long-term administration of an opioid/hypnotic often develop delirium." | 2.71 | Withdrawal following sufentanil/propofol and sufentanil/midazolam. Sedation in surgical ICU patients: correlation with central nervous parameters and endogenous opioids. ( Freye, EC; Korak-Leiter, M; Levy, JV; Likar, R; Oher, M; Trampitsch, E; Ziervogel, G, 2005) |
"When midazolam was administered for the treatment of severe agitation it reduced the severity but did not abolish agitation." | 2.70 | [Prevention of "post-sevoflurane delirium" with midazolam]. ( Bressem, M; Kulka, PJ; Tryba, M; Wiebalck, A, 2001) |
"Dyspnea and delirium are the two most commonly treated symptoms." | 2.53 | A Review of Palliative Sedation. ( Bobb, B, 2016) |
"Delirium is defined by a fluctuating level of attentiveness and has been associated with increased ICU mortality and poor cognitive outcomes in both general ICU and neurocritical care populations." | 2.47 | Delirium and sedation in the ICU. ( Frontera, JA, 2011) |
"Terminal restlessness is a variant of delirium observed in some patients in their last days of life." | 2.40 | Palliative care: an update on "terminal restlessness". ( Burke, AL, 1997) |
"The most prevalent symptoms were: breathlessness, weakness/lack of energy, drowsiness, anxiety, agitation, confusion/delirium, and pain." | 1.72 | Symptom Control and Survival for People Severely ill With COVID: A Multicentre Cohort Study (CovPall-Symptom). ( Bajwah, S; Bradshaw, A; Chambers, RL; Dunleavy, L; Fraser, LK; Higginson, IJ; Hocaoglu, MB; Maddocks, M; Murtagh, FEM; Oluyase, AO; Preston, N; Sleeman, KE; Walshe, C, 2022) |
"Midazolam is a widely used short-acting benzodiazepine." | 1.72 | Midazolam impacts acetyl-And butyrylcholinesterase genes: An epigenetic explanation for postoperative delirium? ( Adamzik, M; Bazzi, M; Bazzi, Z; Bergmann, L; Holtkamp, C; Koos, B; Nowak, H; Orlowski, J; Rahmel, T; Rump, K; Thon, P; Unterberg, M, 2022) |
"Midazolam was the most common medication used (57." | 1.72 | Refractory hyperactive delirium in the dying: pharmacological management. ( Rashed, S; Shiu, A; Tham, K; Walpole, G; William, L, 2022) |
"During the study period, 552 cancer patients died at the institution and 374 met the inclusion criteria for this study." | 1.48 | Continuous palliative sedation for patients with advanced cancer at a tertiary care cancer center. ( Del Giglio, A; Eiger, D; França, MS; Gomes, DBD; Hui, D; Mariano, RC; Prado, BL; Taranto, P; Usón Júnior, PLS, 2018) |
"Non-pharmacological treatment for ICU delirium was reported by only 45% of the respondents." | 1.46 | Multicenter assessment of sedation and delirium practices in the intensive care units in Poland - is this common practice in Eastern Europe? ( Ely, EW; Kaczmarczyk, M; Kotfis, K; Kusza, K; Zegan-Barańska, M; Żukowski, M, 2017) |
"Infant delirium is an under-recognized clinical entity in neonatal intensive care, and earlier identification and treatment could minimize morbidities associated with this condition." | 1.46 | A case of infant delirium in the neonatal intensive care unit. ( Bidegain, M; Cotten, CM; Edwards, LE; Hornik, CD; Hutchison, LB; Smith, PB, 2017) |
"Delirium was the most frequent reason for PS (n = 15, 75%)." | 1.46 | Bispectral Index monitoring in cancer patients undergoing palliative sedation: a preliminary report. ( Allende-Pérez, S; Bruera, E; García-Salamanca, MF; Hui, D; Monreal-Carrillo, E; Verástegui, E, 2017) |
"Midazolam treatment resulted on average in a statistically significant reduction of the BIS values (-4." | 1.43 | Bispectral Index Monitoring in Terminally Ill Patients: A Validation Study. ( Baar, FP; Blussé van Oud-Alblas, HJ; Ista, E; Masman, AD; Tibboel, D; van Dijk, M; van Rosmalen, J, 2016) |
"Delirium is an important complication in palliative care patients." | 1.43 | The Impact of Plasma Cholinergic Enzyme Activity and Other Risk Factors for the Development of Delirium in Patients Receiving Palliative Care. ( Bardenheuer, HJ; Frankenhauser, S; Kopitz, J; Petersen, KA; Plaschke, K; Weigand, MA, 2016) |
"Propofol (89%) use was common, followed by midazolam (49%)." | 1.42 | A web-based survey of United Kingdom sedation practice in the intensive care unit. ( McKenzie, CA; Terblanche, M; Yassin, J; Yassin, SM, 2015) |
"Delirium was detected at least once in 65% of the patients (n = 640)." | 1.39 | Fluctuations in sedation levels may contribute to delirium in ICU patients. ( Christensen, D; Egerod, I; Frydenberg, M; Svenningsen, H; Tønnesen, EK; Videbech, P, 2013) |
"Midazolam was the drug used in most cases." | 1.38 | A survey of the sedation practice of Portuguese palliative care teams. ( Almeida, A; Barbas, S; Cordero, A; Cruz, A; Feio, M; Gonçalves, F; Neves, S; Rocha, C; Silva, P, 2012) |
"Delirium is still one of the most common and distressing symptoms in palliative care patients." | 1.38 | Reversible delirium in an advanced cancer patient. ( Jagsch, C; Kierner, KA; Watzke, HH, 2012) |
" Reduction of the barbiturate dosage resulted in clinical and subclinical partial seizures appearing repetitively in clusters." | 1.34 | Acute encephalitis with refractory, repetitive partial seizures: case reports of this unusual post-encephalitic epilepsy. ( Inoue, T; Maegaki, Y; Nanba, Y; Ogura, K; Ohno, K; Okamoto, R; Saito, Y; Takahashi, Y; Togawa, M, 2007) |
"Delirium is a common complication in the postoperative period of elderly patients treated for hip fractures." | 1.33 | Incidence, clinical features and subtypes of delirium in elderly patients treated for hip fractures. ( Eriksdotter Jonhagen, M; Santana Santos, F; Tadeu Velasco, I; Varli, F; Wahlund, LO, 2005) |
"Midazolam was the most common medication prescribed to achieve sedation." | 1.31 | A multicentre international study of sedation for uncontrolled symptoms in terminally ill patients. ( Bengtson, K; Bercovici, M; deMoissac, D; Fainsinger, RL; Hosking, M; Landman, W; Nunez-Olarte, JM; Waller, A, 2000) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.12) | 18.7374 |
1990's | 7 (7.87) | 18.2507 |
2000's | 13 (14.61) | 29.6817 |
2010's | 51 (57.30) | 24.3611 |
2020's | 17 (19.10) | 2.80 |
Authors | Studies |
---|---|
Tham, K | 1 |
Shiu, A | 1 |
William, L | 1 |
Walpole, G | 1 |
Rashed, S | 1 |
Athanassoglou, V | 1 |
Cozowicz, C | 1 |
Zhong, H | 1 |
Illescas, A | 1 |
Poeran, J | 1 |
Liu, J | 1 |
Poultsides, L | 1 |
Memtsoudis, SG | 1 |
Greengrass, RA | 1 |
Shi, HJ | 1 |
Yuan, RX | 1 |
Zhang, JZ | 1 |
Chen, JH | 1 |
Hu, AM | 1 |
Higginson, IJ | 1 |
Hocaoglu, MB | 1 |
Fraser, LK | 1 |
Maddocks, M | 1 |
Sleeman, KE | 1 |
Oluyase, AO | 1 |
Chambers, RL | 1 |
Preston, N | 1 |
Dunleavy, L | 1 |
Bradshaw, A | 1 |
Bajwah, S | 1 |
Murtagh, FEM | 1 |
Walshe, C | 1 |
Rump, K | 1 |
Holtkamp, C | 1 |
Bergmann, L | 1 |
Nowak, H | 1 |
Unterberg, M | 1 |
Orlowski, J | 1 |
Thon, P | 1 |
Bazzi, Z | 1 |
Bazzi, M | 1 |
Adamzik, M | 1 |
Koos, B | 1 |
Rahmel, T | 1 |
Matsuishi, Y | 1 |
Hoshino, H | 1 |
Enomoto, Y | 1 |
Shimojo, N | 1 |
Matsubara, M | 1 |
Kato, H | 1 |
Mathis, BJ | 1 |
Morita, K | 1 |
Hiramatsu, Y | 1 |
Inoue, Y | 1 |
Wen, J | 1 |
Ding, X | 1 |
Liu, C | 1 |
Jiang, W | 1 |
Xu, Y | 1 |
Wei, X | 1 |
Liu, X | 1 |
Celis-Rodríguez, E | 1 |
Díaz Cortés, JC | 1 |
Cárdenas Bolívar, YR | 1 |
Carrizosa González, JA | 1 |
Pinilla, DI | 1 |
Ferrer Záccaro, LE | 1 |
Birchenall, C | 1 |
Caballero López, J | 1 |
Argüello, BM | 1 |
Castillo Abrego, G | 1 |
Castorena Arellano, G | 1 |
Dueñas Castell, C | 1 |
Jáuregui Solórzano, JM | 1 |
Leal, R | 1 |
Pardo Oviedo, JM | 1 |
Arroyo, M | 1 |
Raffán-Sanabria, F | 1 |
Raimondi, N | 1 |
Reina, R | 1 |
Rodríguez Lima, DR | 1 |
Silesky Jiménez, JI | 1 |
Ugarte Ubiergo, S | 1 |
Gómez Escobar, LG | 1 |
Díaz Aya, DP | 1 |
Fowler, C | 1 |
Nates, JL | 1 |
Michel, J | 1 |
Hofbeck, M | 1 |
Peper, AK | 1 |
Kumpf, M | 1 |
Neunhoeffer, F | 1 |
Yamamoto, T | 1 |
Mizobata, Y | 1 |
Kawazoe, Y | 1 |
Miyamoto, K | 1 |
Ohta, Y | 1 |
Morimoto, T | 1 |
Yamamura, H | 1 |
Olsen, HT | 1 |
Nedergaard, HK | 1 |
Strøm, T | 1 |
Oxlund, J | 1 |
Wian, KA | 1 |
Ytrebø, LM | 1 |
Kroken, BA | 1 |
Chew, M | 1 |
Korkmaz, S | 1 |
Lauridsen, JT | 1 |
Toft, P | 1 |
Wang, L | 1 |
Zhang, T | 1 |
Huang, L | 1 |
Peng, W | 1 |
Bastos, AS | 1 |
Beccaria, LM | 1 |
Silva, DCD | 1 |
Barbosa, TP | 1 |
Jackson, T | 1 |
Hobson, K | 1 |
Clare, H | 1 |
Weegmann, D | 1 |
Moloughney, C | 1 |
McManus, S | 1 |
Lee, D | 1 |
Petersen, F | 1 |
Wu, M | 1 |
Chapman, G | 1 |
Hayman, M | 1 |
Tomkins, K | 1 |
Fernando, J | 1 |
Wang, ML | 1 |
Min, J | 1 |
Sands, LP | 1 |
Leung, JM | 1 |
Monreal-Carrillo, E | 1 |
Allende-Pérez, S | 1 |
Hui, D | 2 |
García-Salamanca, MF | 1 |
Bruera, E | 1 |
Verástegui, E | 1 |
Wang, J | 1 |
Peng, ZY | 1 |
Zhou, WH | 1 |
Hu, B | 1 |
Rao, X | 1 |
Li, JG | 1 |
Sola, C | 1 |
Lefauconnier, A | 1 |
Bringuier, S | 1 |
Raux, O | 1 |
Capdevila, X | 1 |
Dadure, C | 1 |
Neubert, A | 1 |
Baarslag, MA | 1 |
Dijk, MV | 1 |
Rosmalen, JV | 1 |
Standing, JF | 1 |
Sheng, Y | 1 |
Rascher, W | 1 |
Roberts, D | 1 |
Winslade, J | 1 |
Rawcliffe, L | 1 |
Hanning, SM | 1 |
Metsvaht, T | 1 |
Giannuzzi, V | 1 |
Larsson, P | 1 |
Pokorná, P | 1 |
Simonetti, A | 1 |
Tibboel, D | 2 |
Kotfis, K | 1 |
Zegan-Barańska, M | 1 |
Żukowski, M | 1 |
Kusza, K | 1 |
Kaczmarczyk, M | 1 |
Ely, EW | 3 |
Li, QD | 1 |
Wan, XY | 1 |
Zhang, YL | 1 |
Li, SW | 1 |
Han, LL | 1 |
Li, WW | 1 |
Shi, HY | 1 |
Yang, J | 2 |
Zhou, Y | 1 |
Kang, Y | 1 |
Xu, B | 1 |
Wang, P | 1 |
Lv, Y | 1 |
Wang, Z | 1 |
Prado, BL | 1 |
Gomes, DBD | 1 |
Usón Júnior, PLS | 1 |
Taranto, P | 1 |
França, MS | 1 |
Eiger, D | 1 |
Mariano, RC | 1 |
Del Giglio, A | 1 |
Gile, J | 1 |
Scott, B | 1 |
Eckle, T | 1 |
Nunes, SL | 1 |
Forsberg, S | 1 |
Blomqvist, H | 1 |
Berggren, L | 1 |
Sörberg, M | 1 |
Sarapohja, T | 1 |
Wickerts, CJ | 1 |
Garetto, F | 1 |
Cancelli, F | 1 |
Rossi, R | 1 |
Maltoni, M | 1 |
Rey, A | 1 |
Rossetti, AO | 1 |
Miroz, JP | 1 |
Eckert, P | 1 |
Oddo, M | 1 |
Zhong, L | 1 |
Shen, K | 1 |
Zhai, S | 1 |
Chen, T | 1 |
Tao, Q | 1 |
Chen, L | 1 |
Tao, Y | 1 |
Qiu, L | 1 |
Ingravallo, F | 1 |
de Nooijer, K | 1 |
Pucci, V | 1 |
Casini, C | 1 |
Miccinesi, G | 1 |
Rietjens, JAC | 1 |
Morino, P | 1 |
Aydogan, MS | 1 |
Korkmaz, MF | 1 |
Ozgül, U | 1 |
Erdogan, MA | 1 |
Yucel, A | 1 |
Karaman, A | 1 |
Togal, T | 1 |
Durmus, M | 1 |
Colak, C | 1 |
Shehabi, Y | 3 |
Bellomo, R | 1 |
Reade, MC | 1 |
Bailey, M | 1 |
Bass, F | 1 |
Howe, B | 1 |
McArthur, C | 1 |
Murray, L | 1 |
Seppelt, IM | 1 |
Webb, S | 1 |
Weisbrodt, L | 1 |
Zhang, C | 1 |
Li, J | 3 |
Zhao, D | 1 |
Wang, Y | 1 |
Mercadante, S | 1 |
Porzio, G | 1 |
Valle, A | 1 |
Aielli, F | 1 |
Casuccio, A | 1 |
Sun, Y | 1 |
Lu, Y | 1 |
Huang, Y | 1 |
Jiang, H | 1 |
Almenrader, N | 1 |
Galante, D | 1 |
Engelhardt, T | 1 |
Afacan, MA | 1 |
Colak, S | 1 |
Erdogan, MO | 1 |
Kosargelir, M | 1 |
Ibrahim, A | 1 |
Tekesin, K | 1 |
Kandis, H | 1 |
Yassin, SM | 1 |
Terblanche, M | 1 |
Yassin, J | 1 |
McKenzie, CA | 1 |
Mehta, S | 1 |
Cook, D | 1 |
Devlin, JW | 1 |
Skrobik, Y | 2 |
Meade, M | 1 |
Fergusson, D | 1 |
Herridge, M | 1 |
Steinberg, M | 1 |
Granton, J | 1 |
Ferguson, N | 1 |
Tanios, M | 1 |
Dodek, P | 1 |
Fowler, R | 1 |
Burns, K | 1 |
Jacka, M | 1 |
Olafson, K | 1 |
Mallick, R | 1 |
Reynolds, S | 1 |
Keenan, S | 1 |
Burry, L | 1 |
Jackson, BF | 1 |
Beck, LA | 1 |
Losek, JD | 1 |
Jiang, L | 1 |
Ding, S | 1 |
Yan, H | 1 |
Li, Y | 1 |
Zhang, L | 1 |
Chen, X | 1 |
Yin, X | 1 |
Liu, S | 1 |
Tang, X | 1 |
Zhang, J | 2 |
Skrupky, LP | 1 |
Drewry, AM | 1 |
Wessman, B | 1 |
Field, RR | 1 |
Fagley, RE | 1 |
Varghese, L | 1 |
Lieu, A | 1 |
Olatunde, J | 1 |
Micek, ST | 2 |
Kollef, MH | 2 |
Boyle, WA | 1 |
Yang, X | 1 |
Li, Z | 1 |
Gao, C | 1 |
Liu, R | 1 |
Drobish, JK | 1 |
Kelz, MB | 1 |
DiPuppo, PM | 1 |
Cook-Sather, SD | 1 |
Song, R | 1 |
Dong, C | 1 |
Lyu, J | 1 |
Liu, D | 1 |
An, Y | 1 |
Feng, Y | 1 |
Lu, X | 1 |
Li, T | 1 |
Li, ZB | 1 |
Gao, XJ | 1 |
Xu, L | 1 |
Masman, AD | 1 |
van Dijk, M | 1 |
van Rosmalen, J | 1 |
Blussé van Oud-Alblas, HJ | 1 |
Ista, E | 1 |
Baar, FP | 1 |
Choi, JY | 1 |
Kim, JM | 1 |
Kwon, CH | 1 |
Joh, JW | 1 |
Lee, S | 1 |
Park, JB | 1 |
Ko, JS | 1 |
Gwak, MS | 1 |
Kim, GS | 1 |
Kim, SJ | 1 |
Lee, SK | 1 |
Zhang, P | 1 |
Austin, E | 1 |
Thompson, M | 1 |
Lin, S | 1 |
Cameron, R | 1 |
Plaschke, K | 1 |
Petersen, KA | 1 |
Frankenhauser, S | 1 |
Weigand, MA | 1 |
Kopitz, J | 1 |
Bardenheuer, HJ | 1 |
Bobb, B | 1 |
Edwards, LE | 1 |
Hutchison, LB | 1 |
Hornik, CD | 1 |
Smith, PB | 1 |
Cotten, CM | 1 |
Bidegain, M | 1 |
Riker, RR | 2 |
Bokesch, PM | 2 |
Ceraso, D | 1 |
Wisemandle, W | 2 |
Koura, F | 1 |
Whitten, P | 1 |
Margolis, BD | 1 |
Byrne, DW | 1 |
Rocha, MG | 1 |
Chen, J | 1 |
Li, W | 1 |
Hu, X | 1 |
Wang, D | 1 |
Shintani, A | 1 |
Joffe, A | 1 |
Coursin, DB | 1 |
Lusthof, KJ | 1 |
Oosting, R | 1 |
Maes, A | 1 |
Verschraagen, M | 1 |
Dijkhuizen, A | 1 |
Sprong, AG | 1 |
Frontera, JA | 1 |
Yapici, N | 1 |
Coruh, T | 1 |
Kehlibar, T | 1 |
Yapici, F | 1 |
Tarhan, A | 1 |
Can, Y | 1 |
Ozler, A | 1 |
Aykac, Z | 1 |
Sharshar, T | 1 |
Porcher, R | 1 |
Siami, S | 1 |
Rohaut, B | 1 |
Bailly-Salin, J | 1 |
Hopkinson, NS | 1 |
Clair, B | 1 |
Guidoux, C | 1 |
Iacobone, E | 1 |
Sonneville, R | 1 |
Polito, A | 1 |
Aboab, J | 1 |
Gaudry, S | 1 |
Morla, O | 1 |
Amouyal, G | 1 |
Azuar, J | 1 |
Allary, J | 1 |
Vieillard-Baron, A | 1 |
Wolff, M | 1 |
Cariou, A | 1 |
Annane, D | 1 |
Kierner, KA | 1 |
Jagsch, C | 1 |
Watzke, HH | 1 |
Gonçalves, F | 1 |
Cordero, A | 1 |
Almeida, A | 1 |
Cruz, A | 1 |
Rocha, C | 1 |
Feio, M | 1 |
Silva, P | 1 |
Barbas, S | 1 |
Neves, S | 1 |
Taipale, PG | 1 |
Ratner, PA | 1 |
Galdas, PM | 1 |
Jillings, C | 1 |
Manning, D | 1 |
Fernandes, C | 1 |
Gallaher, J | 1 |
Colombo, R | 1 |
Corona, A | 1 |
Praga, F | 1 |
Minari, C | 1 |
Giannotti, C | 1 |
Castelli, A | 1 |
Raimondi, F | 1 |
Svenningsen, H | 1 |
Egerod, I | 1 |
Videbech, P | 1 |
Christensen, D | 1 |
Frydenberg, M | 1 |
Tønnesen, EK | 1 |
Leger, C | 1 |
Cossette, M | 1 |
Michaud, V | 1 |
Turgeon, J | 1 |
Sykes, N | 1 |
Thorns, A | 1 |
Korak-Leiter, M | 1 |
Likar, R | 2 |
Oher, M | 1 |
Trampitsch, E | 1 |
Ziervogel, G | 1 |
Levy, JV | 1 |
Freye, EC | 1 |
Anand, NJ | 1 |
Laible, BR | 1 |
Shannon, WD | 1 |
Santana Santos, F | 1 |
Wahlund, LO | 1 |
Varli, F | 1 |
Tadeu Velasco, I | 1 |
Eriksdotter Jonhagen, M | 1 |
Saito, Y | 1 |
Maegaki, Y | 1 |
Okamoto, R | 1 |
Ogura, K | 1 |
Togawa, M | 1 |
Nanba, Y | 1 |
Inoue, T | 1 |
Takahashi, Y | 1 |
Ohno, K | 1 |
Mohri-Ikuzawa, Y | 1 |
Inada, H | 1 |
Takahashi, N | 1 |
Kohase, H | 1 |
Jinno, S | 1 |
Umino, M | 1 |
Breschan, C | 1 |
Platzer, M | 1 |
Jost, R | 1 |
Stettner, H | 1 |
Funk, W | 1 |
Hollnberger, H | 1 |
Geroldinger, J | 1 |
Jost, U | 1 |
Schmid, A | 1 |
Ruppert, M | 1 |
Levänen, J | 1 |
Mäkelä, ML | 1 |
Scheinin, H | 1 |
Hollman, GA | 1 |
Doyle, WL | 1 |
Perrin, L | 1 |
Ramani, S | 1 |
Karnad, AB | 1 |
Burke, AL | 2 |
Verhagen, EH | 1 |
Eliel, MR | 1 |
de Graeff, A | 1 |
Teunissen, SC | 1 |
Fainsinger, RL | 1 |
Waller, A | 1 |
Bercovici, M | 1 |
Bengtson, K | 1 |
Landman, W | 1 |
Hosking, M | 1 |
Nunez-Olarte, JM | 1 |
deMoissac, D | 1 |
Kulka, PJ | 1 |
Bressem, M | 1 |
Wiebalck, A | 1 |
Tryba, M | 1 |
Granberg Axèll, AI | 1 |
Malmros, CW | 1 |
Bergbom, IL | 1 |
Lundberg, DB | 1 |
Cole, JW | 1 |
Murray, DJ | 1 |
McAllister, JD | 1 |
Hirshberg, GE | 1 |
Diamond, PL | 1 |
Hulbert, J | 1 |
Yeatman, J | 1 |
Farr, EA | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Modified Hospital Elder Life Program at Intensive Care Unit: A Stepped-Wedge Cluster Randomized Controlled Trial[NCT06054828] | 266 participants (Anticipated) | Interventional | 2023-09-05 | Recruiting | |||
Non-sedation Versus Sedation With a Daily Wake-up Trial in Critically Ill Patients Receiving Mechanical Ventilation. The NONSEDA-trial. An Investigator-initiated, Randomised, Clinical, Parallel-group, Multinational, Superiority Trial[NCT01967680] | 700 participants (Actual) | Interventional | 2014-01-31 | Completed | |||
Benzodiazepine-free Cardiac Anesthesia for Reduction of Postoperative Delirium[NCT03928236] | 15,886 participants (Anticipated) | Interventional | 2019-11-18 | Active, not recruiting | |||
Impact of Preoperative Midazolam on Outcome of Elderly Patients: a Multicentre Randomised Controlled Trial[NCT03052660] | Phase 4 | 782 participants (Actual) | Interventional | 2017-10-12 | Completed | ||
A Survey of Management of Analgesia, Sedation and Delirium in ICU Patients in China[NCT04217915] | 800 participants (Anticipated) | Observational | 2021-07-12 | Recruiting | |||
A Double Blind, Randomised, Multicentre, Active Controlled, Parallel-group, Phase III Trial to Evaluate the Efficacy, Safety and Pharmacokinetics of Intravenous Clonidine (Hydrochloride) Compared to Midazolam for Sedation in Children From Birth to Less Th[NCT02509273] | Phase 3 | 28 participants (Actual) | Interventional | 2016-05-31 | Terminated (stopped due to lack of recruitment) | ||
Non-interventional Comparison of Sedatives on Weaning From Mechanical Ventilation in Intensive Care Patients[NCT01707680] | 155 participants (Actual) | Observational | 2012-06-01 | Terminated (stopped due to Halted due to slow recruitment) | |||
A Randomized, Double-Blinded, Placebo Controlled Trial Using Single Dose Dexmedetomidine In The Treatment Of Pain In Patients Undergoing Cleft Palate Repair[NCT02915042] | Phase 4 | 0 participants (Actual) | Interventional | 2017-12-31 | Withdrawn (stopped due to Recruitment concerns) | ||
Prospective, Randomized, Double-blind, Double-dummy, Active-controlled, Phase 3 Clinical Trial Comparing the Safety and Efficacy of Intranasal Dexmedetomidine to Oral Midazolam as Premedication for Propofol Sedation in Pediatric Patients Undergoing Magnet[NCT05192629] | Phase 3 | 250 participants (Anticipated) | Interventional | 2022-03-09 | Recruiting | ||
Risk Factors of Delirium in Sequential Sedation Patients in Intensive Care Unit[NCT03194360] | 141 participants (Actual) | Observational | 2015-12-01 | Completed | |||
Effect of Low-dose Dexmedetomidine on Postoperative Delirium in Patients After Cardiac Surgery: A Multicenter, Double-blinded, Randomized Controlled Trial[NCT03624595] | 502 participants (Anticipated) | Interventional | 2019-04-16 | Active, not recruiting | |||
Cardioprotective Effect of Dexmedetomidine in Patients With ST-segment Elevation Myocardial Infarction: a Double-Blind, Multicenter, Randomized, Placebo-Controlled Clinical Trial[NCT04912518] | 250 participants (Anticipated) | Interventional | 2021-05-27 | Recruiting | |||
Impact of Dexmedetomidine Supplemented Analgesia on Long-term Survival in Elderly Patients After Cancer Surgery: a Multicenter Randomized Controlled Trial[NCT03012971] | 1,500 participants (Actual) | Interventional | 2017-01-06 | Active, not recruiting | |||
A Phase 4, Randomized, Double-Blind, Multi-Center, Comparator Study Evaluating the Safety and Efficacy of Dexmedetomidine Compared to IV Midazolam in ICU Subjects Requiring Greater Than Twenty-Four Hours of Continuous Sedation[NCT00216190] | Phase 4 | 420 participants (Actual) | Interventional | 2005-03-31 | Completed | ||
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Dexmedetomidine (Precedex®), With Lorazepam Rescue, for the Management of Severe Alcohol Withdrawal Syndrome (AWS) and Alcohol Withdrawal Delirium (AWD)[NCT01362205] | Phase 4 | 49 participants (Actual) | Interventional | 2012-03-31 | Terminated (stopped due to DSMB recommendation for slow enrollment) | ||
Impact of Low-dose Dexmedetomidine on Outcomes of Elderly Admitted to ICU After Noncardiac Surgery: a Randomized Controlled Trial[NCT04204798] | 1,410 participants (Anticipated) | Interventional | 2020-08-28 | Recruiting | |||
Dex vs Dazzle: Dexmedetomidine vs Midazolam for Intraoperative Sedation[NCT02878837] | Phase 4 | 120 participants (Actual) | Interventional | 2016-01-31 | Completed | ||
Multicentric, Single Blind, Randomized Controlled Trial on Enteral Sedation Versus Intravenous Sedation in Critically Ill High-risk ICU Patients[NCT01360346] | Phase 3 | 300 participants (Anticipated) | Interventional | 2012-01-31 | Recruiting | ||
Pain, Agitation and Delirium Protocol in Ventilated Patients in the Duke CICU[NCT02903407] | Phase 4 | 7 participants (Actual) | Interventional | 2017-09-01 | Terminated (stopped due to All enrolled participants completed the study protocol but the study was terminated prior to the goal number of participants due to low recruitment) | ||
Dynamic Light Application to Prevent ICU Acquired Delirium[NCT01274819] | 1,000 participants (Actual) | Interventional | 2011-07-31 | Completed | |||
Effect of Clonidine vs. Dexmedetomidine in Addition to Standard Treatment in Agitated Delirium in Intensive Care Patients: Pilot Study.[NCT04758936] | Phase 4 | 50 participants (Anticipated) | Interventional | 2021-02-01 | Recruiting | ||
Impact of Dexmedetomidine Supplemented Analgesia on Incidence of Delirium in Elderly Patients After Cancer Surgery: a Multicenter Randomized Controlled Trial[NCT03012984] | 1,500 participants (Actual) | Interventional | 2017-01-06 | Completed | |||
Etomidate With Meperidine vs Midazolam With Meperidine for Sedation During Endodscopic Retrograde Cholangiopancreatogram (ERCP)[NCT02027311] | Phase 4 | 63 participants (Actual) | Interventional | 2013-04-30 | Completed | ||
Evaluation the Efficiency of Intravenous Dexmedetomidine Under Nasal Humidification Rapid Ventilation Device Without Intubation in Laryngoscope Microsurgery[NCT05581485] | 90 participants (Anticipated) | Interventional | 2022-11-29 | Recruiting | |||
Dexmedetomidine Compared to Midazolam for Symptom Control in Advanced Cancer Patients: A Pilot Randomized Controlled Trial (RCT)[NCT01687751] | Phase 2 | 0 participants (Actual) | Interventional | 2012-11-30 | Withdrawn (stopped due to Study design determined to be not likely feasible) | ||
[NCT01506622] | 222 participants (Actual) | Interventional | 2011-01-31 | Completed | |||
Serum Biomarkers in Sepsis Associated Encephalopathy (SAE)[NCT03133208] | 90 participants (Anticipated) | Observational | 2017-06-01 | Recruiting | |||
Southern Medical University Clinical Research Project Initiative:Efficacy and Safety of a Multicomponent Physical Therapy Program in Mechanically Ventilated Patient With Sepsis[NCT03406494] | 800 participants (Anticipated) | Interventional | 2018-03-31 | Not yet recruiting | |||
Opioid Withdrawal Symptoms in Critically Ill Patients[NCT03374722] | 55 participants (Actual) | Observational | 2018-01-01 | Completed | |||
Risk Factors for Delirium in Critically Ill Surgical Patients[NCT03050021] | 251 participants (Actual) | Observational | 2013-04-01 | Completed | |||
Awakening-Breathing Coordination, Delirium Monitoring/Management & Early Mobility (ABCDE) Protocol[NCT01413009] | 200 participants (Actual) | Observational | 2010-12-29 | Completed | |||
Prevention of Nicotine Abstinence in Critically Ill Patients After Major Surgery[NCT03847155] | 52 participants (Actual) | Interventional | 2015-09-23 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Minnesota Detoxification Scale (MINDS) min score 0, max score 46. The higher the score, the worse the symptoms of AWS/AWD. (NCT01362205)
Timeframe: up to 28 days
Intervention | units on a scale (Median) |
---|---|
Dexmedetomidine | 8.2 |
Placebo | 9.4 |
A ventilator day is counted for any use of invasive mechanical ventilation during a calendar day (NCT01362205)
Timeframe: up to 28 days
Intervention | days (Median) |
---|---|
Dexmedetomidine | 27.5 |
Placebo | 28.0 |
(NCT01362205)
Timeframe: Up to 28 days
Intervention | USD (Median) |
---|---|
Dexmedetomidine | 81234 |
Placebo | 91651 |
(NCT01362205)
Timeframe: up to 28 Days
Intervention | Dollar (United States) (Median) |
---|---|
Dexmedetomidine | 3482 |
Placebo | 4461 |
The Beck Anxiety Inventory is a validated questionnaire used to measure severity of anxiety (min score 0, max score 63). The higher the score the greater the severity of anxiety. A score of 30-63 indicates severe anxiety, 17-29 moderate anxiety, 10-16 mild anxiety and 0-9 minimal anxiety. (NCT01362205)
Timeframe: Up to 28 days.
Intervention | units on a scale (Mean) |
---|---|
Dexmedetomidine | 30.3 |
Placebo | 21.6 |
The Beck Depression Inventory is a validated questionnaire used to measure severity of depression (min score 0, max score 63). The higher the score the greater the severity of depression. A score of 30-63 indicates severe depression, 19-29 moderate depression, 10-18 mild depression and 0-9 minimal depression. (NCT01362205)
Timeframe: Up to 28 days.
Intervention | units on a scale (Mean) |
---|---|
Dexmedetomidine | 26.5 |
Placebo | 21.4 |
The Mini Mental State Examination or Folstein test is a validated 30-point questionnaire used to measure cognitive impairment (min score 0, max score 30). A score of 24 points (out of a max of 30) indicates normal cognition, less than or equal to 9 points indicates severe impairment, 10-18 indicates moderate impairment and 19-23 mild impairment. (NCT01362205)
Timeframe: up to 28 days
Intervention | units on a scale (Mean) |
---|---|
Dexmedetomidine | 25.8 |
Placebo | 23.1 |
PTSD checklist consists of 17 questions graded on a scale of 1 to 5. The PTSD score is comprised from the sum of the scores 17 questions. The PTSD score has possible values from to 17 to 85 with higher values indicating greater symptom severity. (NCT01362205)
Timeframe: Up to 28 days
Intervention | units on a scale (Median) |
---|---|
Dexmedetomidine | 45.5 |
Placebo | 32.5 |
A hospital day is counted for any time on a calendar day the patient is admitted to the hospital. Hospital days are inclusive of ICU days. (NCT01362205)
Timeframe: up to 28 days
Intervention | days (Median) |
---|---|
Dexmedetomidine | 8.0 |
Placebo | 12.0 |
(NCT01362205)
Timeframe: up to 28 days in hours
Intervention | hours (Median) |
---|---|
Dexmedetomidine | 79.2 |
Placebo | 104.9 |
The Confusion Assessment Method (CAM)-ICU is a validated instrument used to detect the presence or absence of delirium in the ICU. A delirium free day is counted for any day a patient is negative by the CAM-ICU. The higher the number of CAM-ICU negative days indicates the more days a patient was able to think clearly. (NCT01362205)
Timeframe: up to 28 days
Intervention | days (Median) |
---|---|
Dexmedetomidine | 0.3 |
Placebo | 0.3 |
Index hospitalization length of stay in days (NCT02903407)
Timeframe: One month or hospital discharge, whichever time point comes first
Intervention | Days (Median) |
---|---|
Midazolam | 19.5 |
Propofol or Dexmedetomidine | 30.0 |
All-cause mortality during the hospitalization (NCT02903407)
Timeframe: One month or hospital discharge, whichever time point comes first
Intervention | participants (Number) |
---|---|
Midazolam | 1 |
Propofol or Dexmedetomidine | 1 |
Number of days of admission to the CICU during the index hospitalization (NCT02903407)
Timeframe: One month or hospital discharge, whichever time point comes first
Intervention | Days (Median) |
---|---|
Midazolam | 4.1 |
Propofol or Dexmedetomidine | 10.0 |
The number of days alive and free from delirium or coma during admission will be evaluated among patients with CAM-ICU documented (NCT02903407)
Timeframe: One month or hospital discharge, whichever time point comes first
Intervention | Days (Median) |
---|---|
Midazolam | 14.0 |
The time (in days) from when the clinical care team documents a decision to pursue extubation until the time the patient was extubated (NCT02903407)
Timeframe: One month or hospital discharge, whichever time point comes first
Intervention | Days (Median) |
---|---|
Midazolam | 0 |
Propofol or Dexmedetomidine | 0 |
Following ICU discharge, patient charts will be reviewed to evaluate whether they required reintubation. If so, will determine whether necessity of reintubation was related to delirium. (NCT02903407)
Timeframe: One month or hospital discharge, whichever time point comes first
Intervention | Participants (Count of Participants) |
---|---|
Midazolam | 0 |
Propofol or Dexmedetomidine | 1 |
Patients will be monitored for bradycardia which may be associated with sedation drug. Average heart rate before, during and after use of drug will be recorded for each patient. (NCT02903407)
Timeframe: One month or hospital discharge, whichever time point comes first
Intervention | Participants (Count of Participants) |
---|---|
Midazolam | 0 |
Propofol or Dexmedetomidine | 0 |
Will use the Confusion Assessment Method for the ICU (CAM-ICU) to assess presence of delirium as per standard of care by nurses in the CICU. Patients with CAM-ICU data recorded will be included. (NCT02903407)
Timeframe: One month or hospital discharge, whichever time point comes first
Intervention | Participants (Count of Participants) |
---|---|
Midazolam | 1 |
Patients will be monitored for increased pressor requirement during the CICU stay (NCT02903407)
Timeframe: One month or hospital discharge, whichever time point comes first
Intervention | Participants (Count of Participants) |
---|---|
Midazolam | 2 |
Propofol or Dexmedetomidine | 2 |
Days requiring mechanical ventilation during the initial episode of intubation during the hospitalization (NCT02903407)
Timeframe: One month or hospital discharge, whichever time point comes first
Intervention | Days (Median) |
---|---|
Midazolam | 2.5 |
Propofol or Dexmedetomidine | 6.8 |
Will use the CPOT (Critical-Care Pain Observation Tool) score to assess pain level as per standard of care by nurses in the CICU. The CPOT has a range of 0 to 8. A CPOT score of ≤ 2 = minimal to no pain present and >2 = unacceptable level of pain. Data that is recorded will be evaluated following discharge. (NCT02903407)
Timeframe: One month or hospital discharge, whichever time point comes first
Intervention | score on a scale (Median) |
---|---|
Midazolam | 0.0 |
Propofol or Dexmedetomidine | 0.0 |
Will use RASS (Richmond Agitation and Sedation Scale) to assess level of sedation as per standard of care by nurses in the CICU. Data that is recorded will be evaluated following discharge. The RASS ranges from -5 (unrousable) to +4 (combative) and 0 (zero) = alert and calm and goal sedation is considered a RASS level of 0 to -2. (NCT02903407)
Timeframe: One month or hospital discharge, whichever time point comes first
Intervention | percentage of time (Median) |
---|---|
Midazolam | 63.3 |
Propofol or Dexmedetomidine | 63.2 |
The duration, in days, from withdrawal of sedation for mechanical ventilation until the time of discharge from the ICU (NCT02903407)
Timeframe: One month or hospital discharge, whichever time point comes first
Intervention | Days (Median) |
---|---|
Midazolam | 1.6 |
Propofol or Dexmedetomidine | 5.6 |
Hypoxia defined as peripheral blood oxygen saturation measured by pulse oxymeter < 90% (NCT02027311)
Timeframe: Every 5min in Preoperative, intraoperative phase and 15 min in Recovery phase
Intervention | Hypoxia events (Number) |
---|---|
Midazolam | 19 |
Etomidate | 27 |
The frequency of intervention which was defined as any restraint of the patient's head, arms, or legs if they became agitated, or if patient movement was not controlled with verbal instruction from the endoscopist during the whole intraoperative phases. (NCT02027311)
Timeframe: Throughout the whole ERCP procedure
Intervention | Number of intervention (Mean) |
---|---|
Etomidate | 1.9 |
Midazolam | 7.5 |
10 reviews available for midazolam and Delirium
Article | Year |
---|---|
A comparation of dexmedetomidine and midazolam for sedation in patients with mechanical ventilation in ICU: A systematic review and meta-analysis.
Topics: Bradycardia; Delirium; Dexmedetomidine; Humans; Hypnotics and Sedatives; Intensive Care Units; Midaz | 2023 |
Evidence-based clinical practice guidelines for the management of sedoanalgesia and delirium in critically ill adult patients.
Topics: Analgesia; Anesthesia; Benzodiazepines; Conscious Sedation; Critical Care; Critical Illness; Deliriu | 2020 |
Palliative Sedation for the Terminally Ill Patient.
Topics: Decision Making; Deep Sedation; Delirium; Haloperidol; Humans; Hypnotics and Sedatives; Midazolam; T | 2018 |
Prophylactic midazolam and clonidine for emergence from agitation in children after emergence from sevoflurane anesthesia: a meta-analysis.
Topics: Akathisia, Drug-Induced; Analgesics; Anesthesia; Anesthetics, Inhalation; Anesthetics, Intravenous; | 2013 |
Is dexmedetomidine superior to midazolam as a premedication in children? A meta-analysis of randomized controlled trials.
Topics: Child; Child, Preschool; Delirium; Dexmedetomidine; Heart Rate; Humans; Hypnotics and Sedatives; Mid | 2014 |
Is dexmedetomidine superior to midazolam as a premedication in children? A meta-analysis of randomized controlled trials.
Topics: Child; Child, Preschool; Delirium; Dexmedetomidine; Heart Rate; Humans; Hypnotics and Sedatives; Mid | 2014 |
Is dexmedetomidine superior to midazolam as a premedication in children? A meta-analysis of randomized controlled trials.
Topics: Child; Child, Preschool; Delirium; Dexmedetomidine; Heart Rate; Humans; Hypnotics and Sedatives; Mid | 2014 |
Is dexmedetomidine superior to midazolam as a premedication in children? A meta-analysis of randomized controlled trials.
Topics: Child; Child, Preschool; Delirium; Dexmedetomidine; Heart Rate; Humans; Hypnotics and Sedatives; Mid | 2014 |
A Review of Palliative Sedation.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Delirium; Fatal Outcome; Female; Hum | 2016 |
Delirium and sedation in the ICU.
Topics: Conscious Sedation; Delirium; Dexmedetomidine; Diagnosis, Differential; Hospital Mortality; Humans; | 2011 |
Long-term subcutaneous infusion of midazolam for refractory delirium in terminal breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Delirium; Female; Home Care Services; Humans; Hypnotics and Sedati | 1996 |
Palliative care: an update on "terminal restlessness".
Topics: Anti-Anxiety Agents; Anticonvulsants; Antipsychotic Agents; Clonazepam; Delirium; Diazepam; Humans; | 1997 |
[Sedation in the terminal phase of life].
Topics: Adult; Anti-Anxiety Agents; Conscious Sedation; Delirium; Euthanasia, Passive; Female; Humans; Hypno | 1999 |
20 trials available for midazolam and Delirium
Article | Year |
---|---|
Incidence, risk factors, and outcomes for sepsis-associated delirium in patients with mechanical ventilation: A sub-analysis of a multicenter randomized controlled trial.
Topics: Aged; Aged, 80 and over; Critical Care; Delirium; Female; Fentanyl; Hospital Mortality; Humans; Hypn | 2020 |
Nonsedation or Light Sedation in Critically Ill, Mechanically Ventilated Patients.
Topics: Aged; Aged, 80 and over; Coma; Conscious Sedation; Critical Illness; Delirium; Female; Humans; Hypno | 2020 |
Comparison between Dexmedetomidine and Midazolam for Sedation in Patients with Intubation after Oral and Maxillofacial Surgery.
Topics: Aged; Bradycardia; Conscious Sedation; Delirium; Dexmedetomidine; Female; Humans; Hypnotics and Seda | 2020 |
Childhood preoperative anxiolysis: Is sedation and distraction better than either alone? A prospective randomized study.
Topics: Analgesics; Anti-Anxiety Agents; Anxiety; Child; Child, Preschool; Combined Modality Therapy; Consci | 2017 |
The CLOSED trial; CLOnidine compared with midazolam for SEDation of paediatric patients in the intensive care unit: study protocol for a multicentre randomised controlled trial.
Topics: Adolescent; Analgesics, Opioid; Child; Child Development; Child, Preschool; Clonidine; Delirium; Hum | 2017 |
Pain, fentanyl consumption, and delirium in adolescents after scoliosis surgery: dexmedetomidine vs midazolam.
Topics: Adolescent; Analgesics, Opioid; Anesthesia, General; Arterial Pressure; Child; Conscious Sedation; C | 2013 |
Early goal-directed sedation versus standard sedation in mechanically ventilated critically ill patients: a pilot study*.
Topics: Adrenergic alpha-2 Receptor Agonists; Aged; Airway Extubation; Algorithms; APACHE; Benzodiazepines; | 2013 |
Prevalence, risk factors, and outcomes of delirium in mechanically ventilated adults.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Analgesics, Opioid; Antipsychotic Agents; APACHE; Benzo | 2015 |
Effect of dexmedetomidine on preventing agitation and delirium after microvascular free flap surgery: a randomized, double-blind, control study.
Topics: Adult; Aged; Analgesics, Opioid; Anesthesia Recovery Period; Blood Pressure; Delirium; Dexmedetomidi | 2015 |
[A study of using dexmedetomidine in ventilator bundle treatment in an ICU].
Topics: Arterial Pressure; Blood Pressure; Delirium; Dexmedetomidine; Fentanyl; Humans; Hypnotics and Sedati | 2015 |
[The influence of the sedation based on remifentanil analgesia on the occurrence of delirium in critically ill patients].
Topics: Analgesia; Arterial Pressure; Critical Illness; Delirium; Dexmedetomidine; Humans; Hypnotics and Sed | 2015 |
Clinical study of midazolam sequential with dexmedetomidine for agitated patients undergoing weaning to implement light sedation in intensive care unit.
Topics: Adult; Aged; Critical Care; Delirium; Dexmedetomidine; Female; Humans; Hypnotics and Sedatives; Inte | 2016 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Topics: Adrenergic alpha-Agonists; Aged; APACHE; Conscious Sedation; Critical Illness; Delirium; Dexmedetomi | 2009 |
Emergence agitation after cataract surgery in children: a comparison of midazolam, propofol and ketamine.
Topics: Anesthesia Recovery Period; Anesthesia, General; Anesthetics, Dissociative; Anesthetics, Inhalation; | 2010 |
A reorientation strategy for reducing delirium in the critically ill. Results of an interventional study.
Topics: Acoustic Stimulation; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Critical Care; | 2012 |
Withdrawal following sufentanil/propofol and sufentanil/midazolam. Sedation in surgical ICU patients: correlation with central nervous parameters and endogenous opioids.
Topics: Adolescent; Adult; Aged; Analgesics, Opioid; beta-Endorphin; Blood Pressure; Conscious Sedation; Cri | 2005 |
Midazolam does not reduce emergence delirium after sevoflurane anesthesia in children.
Topics: Administration, Rectal; Age Factors; Akathisia, Drug-Induced; Anesthesia, General; Anesthetics, Inha | 2007 |
Physostigmine and anaesthesia emergence delirium in preschool children: a randomized blinded trial.
Topics: Analgesics; Anesthesia; Anesthetics, Inhalation; Child, Preschool; Delirium; Female; Humans; Intraop | 2008 |
Dexmedetomidine premedication attenuates ketamine-induced cardiostimulatory effects and postanesthetic delirium.
Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Blood Pressure; Delirium; Double-Blind Method; Heart R | 1995 |
[Prevention of "post-sevoflurane delirium" with midazolam].
Topics: Adjuvants, Anesthesia; Anesthetics, Inhalation; Child; Child, Preschool; Delirium; Double-Blind Meth | 2001 |
59 other studies available for midazolam and Delirium
Article | Year |
---|---|
Refractory hyperactive delirium in the dying: pharmacological management.
Topics: Australia; Death; Delirium; Humans; Hypnotics and Sedatives; Midazolam; Palliative Care; Psychomotor | 2022 |
Association of perioperative midazolam use and complications: a population-based analysis.
Topics: Adult; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzodiazepines; Delirium; H | 2022 |
Midazolam and delirium: can you have it both ways?
Topics: Delirium; Humans; Hypnotics and Sedatives; Midazolam | 2022 |
Effect of midazolam on delirium in critically ill patients: a propensity score analysis.
Topics: Cohort Studies; Critical Illness; Delirium; Humans; Intensive Care Units; Length of Stay; Midazolam; | 2022 |
Symptom Control and Survival for People Severely ill With COVID: A Multicentre Cohort Study (CovPall-Symptom).
Topics: Aged; Cohort Studies; COVID-19; Delirium; Dyspnea; Humans; Midazolam; Morphine; Pain; Palliative Car | 2022 |
Midazolam impacts acetyl-And butyrylcholinesterase genes: An epigenetic explanation for postoperative delirium?
Topics: Acetylcholinesterase; Butyrylcholinesterase; Cholinesterase Inhibitors; Delirium; Epigenesis, Geneti | 2022 |
Pediatric delirium is associated with increased brain injury marker levels in cardiac surgery patients.
Topics: Adult; Bayes Theorem; Biomarkers; Brain Injuries; Cardiac Surgical Procedures; Child; Coma; Delirium | 2022 |
Evaluation of an updated sedation protocol to reduce benzodiazepines in a pediatric intensive care unit.
Topics: Analgesia; Anesthesia; Benzodiazepines; Delirium; Female; Humans; Hypnotics and Sedatives; Infant; I | 2020 |
Prevalence of delirium in intensive care patients and association with sedoanalgesia, severity and mortality.
Topics: Analgesics; Chi-Square Distribution; Clonidine; Critical Care; Cross-Sectional Studies; Delirium; Fe | 2020 |
End-of-life care in COVID-19: An audit of pharmacological management in hospital inpatients.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Betacoronavirus; Biopharmaceutics; Coronavirus I | 2020 |
A prospective observational cohort pilot study of the association between midazolam use and delirium in elderly endoscopy patients.
Topics: Aged; Aged, 80 and over; Anesthetics, Intravenous; Australia; Cohort Studies; Delirium; Endoscopy; F | 2021 |
Midazolam Premedication Immediately Before Surgery Is Not Associated With Early Postoperative Delirium.
Topics: Adjuvants, Anesthesia; Administration, Intravenous; Aged; Aged, 80 and over; Databases, Factual; Del | 2021 |
Midazolam Premedication Immediately Before Surgery Is Not Associated With Early Postoperative Delirium.
Topics: Adjuvants, Anesthesia; Administration, Intravenous; Aged; Aged, 80 and over; Databases, Factual; Del | 2021 |
Midazolam Premedication Immediately Before Surgery Is Not Associated With Early Postoperative Delirium.
Topics: Adjuvants, Anesthesia; Administration, Intravenous; Aged; Aged, 80 and over; Databases, Factual; Del | 2021 |
Midazolam Premedication Immediately Before Surgery Is Not Associated With Early Postoperative Delirium.
Topics: Adjuvants, Anesthesia; Administration, Intravenous; Aged; Aged, 80 and over; Databases, Factual; Del | 2021 |
Bispectral Index monitoring in cancer patients undergoing palliative sedation: a preliminary report.
Topics: Adult; Aged; Awareness; Cancer Pain; Conscious Sedation; Consciousness; Delirium; Electroencephalogr | 2017 |
A National Multicenter Survey on Management of Pain, Agitation, and Delirium in Intensive Care Units in China.
Topics: Delirium; Dexmedetomidine; Fentanyl; Haloperidol; Humans; Hypnotics and Sedatives; Intensive Care Un | 2017 |
Multicenter assessment of sedation and delirium practices in the intensive care units in Poland - is this common practice in Eastern Europe?
Topics: Critical Care; Delirium; Europe, Eastern; Humans; Hypnotics and Sedatives; Intensive Care Units; Mid | 2017 |
[The impact of goal directed analgesia on mechanical ventilated patients's outcomes in intensive care unit: a clinical observational study].
Topics: Analgesia; China; Critical Care; Delirium; Dexmedetomidine; Drug Administration Schedule; Goals; Hum | 2017 |
Risk Factors of Delirium in Sequential Sedation Patients in Intensive Care Units.
Topics: Adult; Aged; Anesthesia; Conscious Sedation; Critical Care; Delirium; Dexmedetomidine; Female; Fenta | 2017 |
Continuous palliative sedation for patients with advanced cancer at a tertiary care cancer center.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Deep Sedation; Delirium; Dyspnea; Female; Humans; Hyp | 2018 |
The Period 2 Enhancer Nobiletin as Novel Therapy in Murine Models of Circadian Disruption Resembling Delirium.
Topics: Animals; Chronobiology Disorders; Delirium; Disease Models, Animal; Hippocampus; Memory Disorders; M | 2018 |
Effect of Sedation Regimen on Weaning from Mechanical Ventilation in the Intensive Care Unit.
Topics: Adult; Aged; Aged, 80 and over; Anxiety; Critical Care; Delirium; Dexmedetomidine; Female; Humans; H | 2018 |
Late Awakening in Survivors of Postanoxic Coma: Early Neurophysiologic Predictors and Association With ICU and Long-Term Neurologic Recovery.
Topics: Aged; Cohort Studies; Coma; Delirium; Electroencephalography; Evoked Potentials, Motor; Female; Hear | 2019 |
Application of sedation-agitation scale in conscious sedation before bronchoscopy in children.
Topics: Akathisia, Drug-Induced; Anesthesia, Local; Anti-Anxiety Agents; Anxiety; Bronchoscopy; Child; Child | 2019 |
Discussions about palliative sedation in hospice: Frequency, timing and factors associated with patient involvement.
Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Antipsychotic Agents; Decision Making, Shared; Delirium | 2019 |
Palliative sedation in patients with advanced cancer followed at home: a prospective study.
Topics: Adult; Aged; Aged, 80 and over; Delirium; Dyspnea; Family; Feasibility Studies; Female; Home Care Se | 2014 |
Emergence agitation: is there a European consensus?
Topics: Analgesics, Opioid; Anesthesia Recovery Period; Child; Consensus; Delirium; Europe; Humans; Hypnotic | 2014 |
Lidocaine-induced delirium: a case report.
Topics: Adult; Anesthetics, Local; Anti-Anxiety Agents; Delirium; Diagnostic Imaging; Emergency Service, Hos | 2015 |
A web-based survey of United Kingdom sedation practice in the intensive care unit.
Topics: Alfentanil; Analgesics, Opioid; Conscious Sedation; Critical Care; Data Collection; Deep Sedation; D | 2015 |
Successful flumazenil reversal of paradoxical reaction to midazolam in a child.
Topics: Akathisia, Drug-Induced; Anti-Anxiety Agents; Antidotes; Child, Preschool; Delirium; Female; Flumaze | 2015 |
A retrospective comparison of dexmedetomidine versus midazolam for pediatric patients with congenital heart disease requiring postoperative sedation.
Topics: Anesthetics, Intravenous; Child, Preschool; Delirium; Dexmedetomidine; Dose-Response Relationship, D | 2015 |
Clinical effectiveness of a sedation protocol minimizing benzodiazepine infusions and favoring early dexmedetomidine: a before-after study.
Topics: Adult; Aged; Clinical Protocols; Controlled Before-After Studies; Delirium; Dexmedetomidine; Drug Ad | 2015 |
Emergence delirium with transient associative agnosia and expressive aphasia reversed by flumazenil in a pediatric patient.
Topics: Adjuvants, Anesthesia; Agnosia; Anesthesia, General; Aphasia, Broca; Child; Delirium; Female; Flumaz | 2015 |
Bispectral Index Monitoring in Terminally Ill Patients: A Validation Study.
Topics: Aged; Aged, 80 and over; Brain; Delirium; Electroencephalography; Feasibility Studies; Female; Human | 2016 |
Use of Dexmedetomidine in Liver Transplant Recipients With Postoperative Agitated Delirium.
Topics: Adult; Aged; Antipsychotic Agents; Delirium; Dexmedetomidine; Female; Haloperidol; Humans; Hypnotics | 2016 |
Challenges in a large mixed drug overdose patient.
Topics: Adult; Anticonvulsants; Body Temperature Regulation; Critical Care; Delirium; Diazepam; Drug Overdos | 2016 |
Look again at psychedelic drugs.
Topics: Anxiety; Delirium; Depression; Diazepam; Hallucinogens; Haloperidol; Humans; Lorazepam; Midazolam; P | 2016 |
The Impact of Plasma Cholinergic Enzyme Activity and Other Risk Factors for the Development of Delirium in Patients Receiving Palliative Care.
Topics: Aged; Biomarkers; Cholinergic Antagonists; Cholinesterases; Delirium; Female; Humans; Karnofsky Perf | 2016 |
A case of infant delirium in the neonatal intensive care unit.
Topics: Amines; Analgesics, Opioid; Anti-Anxiety Agents; Cardiac Catheterization; Cyclohexanecarboxylic Acid | 2017 |
Delirium duration and mortality in lightly sedated, mechanically ventilated intensive care patients.
Topics: Aged; Cause of Death; Cohort Studies; Conscious Sedation; Critical Care; Critical Illness; Delirium; | 2010 |
All this confusion is killin' me.
Topics: Case-Control Studies; Conscious Sedation; Critical Care; Critical Illness; Delirium; Dexmedetomidine | 2010 |
A case of extreme agitation and death after the use of mephedrone in The Netherlands.
Topics: Adult; Brain Edema; Central Nervous System Stimulants; Cocaine; Contusions; Delirium; Designer Drugs | 2011 |
Dexmedetomidine in cardiac surgery patients who fail extubation and present with a delirium state.
Topics: Adrenergic alpha-2 Receptor Agonists; Anti-Anxiety Agents; Cardiac Surgical Procedures; Continuous P | 2011 |
Brainstem responses can predict death and delirium in sedated patients in intensive care unit.
Topics: Aged; Aged, 80 and over; Cause of Death; Cohort Studies; Conscious Sedation; Critical Care; Critical | 2011 |
Reversible delirium in an advanced cancer patient.
Topics: Amines; Analgesics; Analgesics, Opioid; Bone Neoplasms; Breast Neoplasms; Carcinoma, Intraductal, No | 2012 |
A survey of the sedation practice of Portuguese palliative care teams.
Topics: Adult; Aged; Aged, 80 and over; Conscious Sedation; Deep Sedation; Delirium; Female; Humans; Hypnoti | 2012 |
The association between nurse-administered midazolam following cardiac surgery and incident delirium: an observational study.
Topics: British Columbia; Delirium; Female; Humans; Hypnotics and Sedatives; Male; Midazolam; Nursing Staff; | 2012 |
Fluctuations in sedation levels may contribute to delirium in ICU patients.
Topics: Aged; Analgesics, Opioid; Cohort Studies; Confusion; Conscious Sedation; Critical Care; Data Collect | 2013 |
Factors predisposing to coma and delirium: fentanyl and midazolam exposure; CYP3A5, ABCB1, and ABCG2 genetic polymorphisms; and inflammatory factors.
Topics: ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member | 2013 |
Sedative use in the last week of life and the implications for end-of-life decision making.
Topics: Adult; Aged; Anticonvulsants; Decision Making; Delirium; Double Effect Principle; Ethics, Clinical; | 2003 |
Delirium as detected by the CAM-ICU predicts restraint use among mechanically ventilated medical patients.
Topics: Adult; Aged; Analgesics, Opioid; Delirium; Female; Fentanyl; Hospital Mortality; Humans; Hypnotics a | 2005 |
Delirium as detected by the CAM-ICU predicts restraint use among mechanically ventilated medical patients.
Topics: Adult; Aged; Analgesics, Opioid; Delirium; Female; Fentanyl; Hospital Mortality; Humans; Hypnotics a | 2005 |
Delirium as detected by the CAM-ICU predicts restraint use among mechanically ventilated medical patients.
Topics: Adult; Aged; Analgesics, Opioid; Delirium; Female; Fentanyl; Hospital Mortality; Humans; Hypnotics a | 2005 |
Delirium as detected by the CAM-ICU predicts restraint use among mechanically ventilated medical patients.
Topics: Adult; Aged; Analgesics, Opioid; Delirium; Female; Fentanyl; Hospital Mortality; Humans; Hypnotics a | 2005 |
Incidence, clinical features and subtypes of delirium in elderly patients treated for hip fractures.
Topics: Age Factors; Aged; Aged, 80 and over; Delirium; Female; Fracture Fixation, Internal; Hip Fractures; | 2005 |
Acute encephalitis with refractory, repetitive partial seizures: case reports of this unusual post-encephalitic epilepsy.
Topics: Acute Disease; Anti-Inflammatory Agents; Anticonvulsants; Brain; Cell Count; Cerebrospinal Fluid; Ch | 2007 |
Delirium during intravenous sedation with midazolam alone and with propofol in dental treatment.
Topics: Alveolar Ridge Augmentation; Anesthesia, Dental; Anesthetics, Combined; Anesthetics, Intravenous; Co | 2006 |
[Physostigmine reversal of central anticholinergic syndrome induced by midazolam/fentanyl, benzoctamine/buprenorphine and etomidate/carticaine or by atropine/promethazine/pethidine for premedication? (author's transl)].
Topics: Adult; Aged; Anthracenes; Atropine; Benzodiazepines; Buprenorphine; Carticaine; Coma; Delirium; Etom | 1982 |
Oral midazolam and emergence delirium.
Topics: Akathisia, Drug-Induced; Delirium; Humans; Infant; Midazolam | 1995 |
Emergence delirium in a child given oral midazolam for conscious sedation.
Topics: Administration, Oral; Animals; Bites and Stings; Child, Preschool; Conscious Sedation; Delirium; Dog | 1994 |
A multicentre international study of sedation for uncontrolled symptoms in terminally ill patients.
Topics: Aged; Analgesics, Opioid; Anti-Anxiety Agents; Consciousness; Delirium; Drug Therapy, Combination; D | 2000 |
Intensive care unit syndrome/delirium is associated with anemia, drug therapy and duration of ventilation treatment.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Analgesics, Opioid; Anemia; Delirium; Female; Fentanyl; | 2002 |
Emergence behaviour in children: defining the incidence of excitement and agitation following anaesthesia.
Topics: Abdomen; Adjuvants, Anesthesia; Age Factors; Ambulatory Surgical Procedures; Anesthesia; Anesthesia | 2002 |
Terminal restlessness--its management and the role of midazolam.
Topics: Aged; Aged, 80 and over; Delirium; Female; Humans; Male; Midazolam; Middle Aged; Neoplasms; Terminal | 1991 |